ST天圣：收到行政处罚决定书

Core Viewpoint - ST Tian Sheng Pharmaceutical Group Co., Ltd. and its controlling shareholder Liu Qun received an administrative penalty from the China Securities Regulatory Commission for financial misconduct, including inflated profits in annual reports for 2017 and 2018 [1] Financial Misconduct - In 2017, ST Tian Sheng inflated its total profit by 92,204,254.47 yuan, which accounted for 30.21% of the reported profit for that year [1] - In 2018, the inflated profit was 28,823,001.51 yuan, representing 20.61% of the reported profit for that year [1] - The company failed to timely disclose related party transactions, leading to significant omissions in the annual reports for both years [1] Penalties Imposed - The Chongqing Securities Regulatory Bureau ordered ST Tian Sheng to rectify its actions, issued a warning, and imposed a fine of 600,000 yuan [1] - Liu Qun received a warning and was fined 900,000 yuan, which included 300,000 yuan for being the directly responsible supervisor and 600,000 yuan for instructing illegal activities as the controlling shareholder [1] - Other individuals involved received varying fines and warnings, with penalties ranging from 120,000 yuan to 300,000 yuan [1] Market Bans - Liu Qun is subject to a lifetime ban from the securities market [1] - Li Hong faces an 8-year ban, while Wang Yonghong is banned for 5 years [1]